Clinical Trials Browser

Influenza, Human

NCT03955991 2025-06-26

VSMART

Phase 4 Completed

109 enrolled

Breast

Breast Neoplasms, Influenza, Human

NCT06124131 2025-05-04

BENEFIT-C

Phase NA Completed

50 enrolled 15 charts

Gastrointestinal

Vaccine-Preventable Diseases, COVID-19, Vaccination Hesitancy, Influenza, Human, Patient Acceptance of Health Care, Colorectal Neoplasms, Health Behavior

NCT02860039 2024-10-22

High Dose Flu Vaccine in Treating Children Who Have Undergone Donor Stem Cell Transplant

Phase 2 Completed

170 enrolled 11 charts

Influenza, Human, Neoplasms

NCT03061955 2024-10-04

Safety and Efficacy of Concurrent Administration of Influenza Vaccine in Patients Undergoing Anti-PD-1 Immunotherapy (Nivolumab, Pembrolizumab)

Completed

28 enrolled

Influenza, Human, Neoplasms

NCT05116917 2024-05-28

INFLUENCE

Phase 2 Terminated

19 enrolled

Gastrointestinal

Influenza, Human, Pancreatic Neoplasms

NCT04355806 2020-04-21

Impact of Inactivated Trivalent Influenza Vaccine on NSCLC Patients Receiving PD-1 / PD-L1 Inhibitors

Unknown

160 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Influenza, Human

NCT03590808 2019-09-19

Influenza Vaccination in Patients Receiving Immune Checkpoint Inhibitor

Phase NA Completed

143 enrolled

Influenza, Human

NCT02566265 2019-01-30

SHIVERING 2

Phase 2 Completed

122 enrolled 10 charts

LymphoidPlasma cell

Influenza, Human, Waldenstrom Macroglobulinemia, Multiple Myeloma

NCT01215981 2017-12-28

Influenza Vaccine Post Allogeneic Transplant

Phase NA Terminated

68 enrolled 6 charts

Other hematologic neoplasm

Influenza, Human, Hematologic Neoplasms

NCT01205581 2016-09-23

Immunogenicity of Fluzone HD,A High Dose Influenza Vaccine, In Children With Cancer or HIV

Phase 2 Completed

85 enrolled 24 charts

Influenza, Human, Neoplasms

NCT01666782 2016-06-24

IMMUNE

Phase 2 Completed

105 enrolled 10 charts

Influenza, Human, Neoplasms

NCT01698177 2013-04-19

Optimizing Influenza Vaccination in Surgical Oncology Patients

Phase 4 Unknown

204 enrolled

Influenza, Human, Neoplasms

NCT01031719 2012-09-13

Clinical Trial to Compare the Immunogenicity, Safety, and Tolerability of an Adjuvanted A(H1N1) Influenza Vaccine Versus Non-Adjuvanted A(H1N1) Influenza Vaccines in Patients With Invasive Solid Tumors

Phase 3 Completed

59 enrolled

Influenza, Human, Neoplasms, Virus Diseases

Clinical Trials

VRiC

VSMART

BENEFIT-C

High Dose Flu Vaccine in Treating Children Who Have Undergone Donor Stem Cell Transplant

Safety and Efficacy of Concurrent Administration of Influenza Vaccine in Patients Undergoing Anti-PD-1 Immunotherapy (Nivolumab, Pembrolizumab)

INFLUENCE

Impact of Inactivated Trivalent Influenza Vaccine on NSCLC Patients Receiving PD-1 / PD-L1 Inhibitors

Influenza Vaccination in Patients Receiving Immune Checkpoint Inhibitor

SHIVERING 2

Influenza Vaccine Post Allogeneic Transplant

Immunogenicity of Fluzone HD,A High Dose Influenza Vaccine, In Children With Cancer or HIV

IMMUNE

Optimizing Influenza Vaccination in Surgical Oncology Patients

Clinical Trial to Compare the Immunogenicity, Safety, and Tolerability of an Adjuvanted A(H1N1) Influenza Vaccine Versus Non-Adjuvanted A(H1N1) Influenza Vaccines in Patients With Invasive Solid Tumors